A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk

CE Wakefield; B Meiser; J Homewood; M Peate; A Taylor; E Lobb; J Kirk; MA Young; R Williams; T Dudding; K Tucker; K Barlow-Stewart; G Fenton; A Goodwin; P Zodgekar; L Andrews; J Koeler; A Overkov; J Tyler; B Warner; M Gleeson; C Groombridge; S O'Donnell; A Spigelman; C McMahon; L Hossack; M Kentwell; C Aragona; R D'Souza; C Gaff; L Hodgkin; R Ward; P Butow; H Davey

Journal article

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk

CE Wakefield, B Meiser, J Homewood, M Peate, A Taylor, E Lobb, J Kirk, MA Young, R Williams, T Dudding, K Tucker, K Barlow-Stewart, G Fenton, A Goodwin, P Zodgekar, L Andrews, J Koeler, A Overkov, J Tyler, B Warner Show all

Breast Cancer Research and Treatment | SPRINGER | Published : 2008

DOI: 10.1007/s10549-007-9539-2

Abstract

Purpose: To measure the effectiveness of a tailored decision aid (DA) designed to help women make informed decisions about genetic testing for breast/ovarian cancer risk. Methods: A total of 145 women were randomized to receive the DA or a control pamphlet at the end of their first genetic counseling consultation. Of these, 120 (82.8%) completed two questionnaires, 1 week and 6 months post-consultation. Results: While the DA had no effect on informed choice, post-decisional regret or actual genetic testing decision, the trial showed that women who received the DA had higher knowledge levels and felt more informed about genetic testing than women who received the control pamphlet (χ 2(2) = 6...

View full abstract